4//SEC Filing
WELTZIEN LOURDES 4
Accession 0001127602-22-005441
CIK 0000794172other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 11:22 AM ET
Size
12.0 KB
Accession
0001127602-22-005441
Insider Transaction Report
Form 4
WELTZIEN LOURDES
EVP, Life Science
Transactions
- Sale
Common Stock
2022-02-15$25.60/sh−20,000$511,912→ 83,048 total - Exercise/Conversion
Stock Options (Right to Buy)
2022-02-15−12,500→ 0 totalExercise: $14.65Exp: 2027-11-08→ Common Stock (12,500 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2022-02-15−7,500→ 2,500 totalExercise: $14.30Exp: 2028-04-24→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2022-02-15$14.30/sh+7,500$107,250→ 103,048 total - Exercise/Conversion
Common Stock
2022-02-15$14.65/sh+12,500$183,125→ 95,548 total
Footnotes (3)
- [F1]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $25.29 to $26.07. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- [F2]These non-qualified options were awarded under the 2012 Stock Incentive Plan and cliff vested in full on November 15, 2021.
- [F3]These options were awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant until fully vested on April 24, 2022.
Documents
Issuer
MERIDIAN BIOSCIENCE INC
CIK 0000794172
Entity typeother
Related Parties
1- filerCIK 0001201184
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 11:22 AM ET
- Size
- 12.0 KB